---
schema_version: "secwatch.filing_event.v1"
accession: "0000721371-24-000030"
form_type: "8-K"
ticker: "CAH"
cik: "0000721371"
company_name: "CARDINAL HEALTH INC"
filed_at: "2024-04-23T23:59:59+00:00"
generated_at: "2026-06-03T12:48:22.875625+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cardinal Health recasts segment results under new structure for FY2022-H1 FY2024

## Summary
- New segments: Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution; three smaller ops reported as Other.
- Recast unaudited quarterly data for FY2022, FY2023, and H1 FY2024; no change to consolidated revenue or net income.
- Pharm & Spec Solutions segment profit grew 13% in FY2023 to $1,862M; H1 FY2024 profit $961M.
- Global Medical Products & Distribution segment losses: FY2022 loss $49M, FY2023 loss $162M, H1 FY2024 loss $2M.
- Total segment revenue grew 13% in FY2023 to $205.1B; H1 FY2024 up 11% to $112.2B.

## SEC filing metadata
- accession: 0000721371-24-000030
- form_type: 8-K
- ticker: CAH
- cik: 0000721371
- company_name: CARDINAL HEALTH INC
- filed_at: 2024-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/721371/000072137124000030/0000721371-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/721371/000072137124000030/cah-20240423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000721371-24-000030
- JSON: https://secwatch.observer/filing/0000721371-24-000030.json
- Plain text: https://secwatch.observer/filing/0000721371-24-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.